Filtering noise from a signal subjected to blanking
    31.
    发明授权
    Filtering noise from a signal subjected to blanking 有权
    过滤来自消隐信号的噪声

    公开(公告)号:US09375181B2

    公开(公告)日:2016-06-28

    申请号:US14522938

    申请日:2014-10-24

    Abstract: The disclosure describes techniques and systems for filtering noise from a physiological signal. In one example, one or more processors are configured to receive a signal indicative of physiological activity of a patient, wherein the signal comprises noise at one or more frequencies, and filter the noise from the signal according to a noise rejection model, wherein the noise rejection model predicts the noise at the one or more frequencies. The one or more processors may also be configured to, responsive to initiation of a blanking period for the signal, advance the noise rejection model in time during the blanking period, and, responsive to termination of the blanking period, filter, based on the noise rejection model advanced in time, the noise at the one or more frequencies from the signal.

    Abstract translation: 本公开描述了用于从生理信号滤波噪声的技术和系统。 在一个示例中,一个或多个处理器被配置为接收指示患者的生理活动的信号,其中所述信号包括一个或多个频率的噪声,并且根据噪声抑制模型对来自信号的噪声进行滤波,其中噪声 拒绝模型预测在一个或多个频率的噪声。 一个或多个处理器还可以被配置为响应于信号的消隐周期的启动,在消隐周期期间及时推进噪声抑制模型,并且响应于消隐周期的终止,基于噪声进行滤波 拒绝模式及时提前,噪声在一个或多个频率的信号。

    Medical device and method for detecting electrical signal noise

    公开(公告)号:US12295736B2

    公开(公告)日:2025-05-13

    申请号:US18193457

    申请日:2023-03-30

    Abstract: A medical device is configured to sense an electrical signal and determine that signal to noise criteria are met based on electrical signal segments stored in response to sensed electrophysiological events. The medical device is configured to determine an increased gain signal segment from one of the stored electrical signal segments in response to determining that the signal to noise criteria are met. The medical device determines a noise metric from the increased gain signal segment. The stored electrical signal segment associated with the increased gain signal segment may be classified as a noise segment in response to the noise metric meeting noise detection criteria.

    System and method for sensing and detection in an extra-cardiovascular implantable cardioverter defibrillator

    公开(公告)号:US12274889B2

    公开(公告)日:2025-04-15

    申请号:US17812974

    申请日:2022-07-15

    Abstract: An extra-cardiovascular implantable cardioverter defibrillator senses R-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal in response to each sensed R-wave. The ICD determines intervals between successively sensed R-waves and, in response to at least a predetermined number of the intervals being less than a tachyarrhythmia detection interval, analyzes at least a portion of the time segment of the second cardiac electrical signal corresponding to a most recent one of the sensed R-waves to confirm the most recent one of the R-waves. The ICD updates an unconfirmed beat count in response to the most recent one of the R-waves not being confirmed and withholds detection of a tachyarrhythmia episode in response to the unconfirmed beat count being equal to or greater than a rejection threshold.

    Medical device and method for detecting electrical signal noise

    公开(公告)号:US11617534B2

    公开(公告)日:2023-04-04

    申请号:US17172770

    申请日:2021-02-10

    Abstract: A medical device is configured to sense an electrical signal and determine that signal to noise criteria are met based on electrical signal segments stored in response to sensed electrophysiological events. The medical device is configured to determine an increased gain signal segment from one of the stored electrical signal segments in response to determining that the signal to noise criteria are met. The medical device determines a noise metric from the increased gain signal segment. The stored electrical signal segment associated with the increased gain signal segment may be classified as a noise segment in response to the noise metric meeting noise detection criteria.

    Systems and methods for leadless pacing and shock therapy

    公开(公告)号:US11033743B2

    公开(公告)日:2021-06-15

    申请号:US16390838

    申请日:2019-04-22

    Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.

Patent Agency Ranking